Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan
· Delayed Price · Currency is TWD 47.50
-0.85 (-1.76%)
May 14, 2025, 10:30 AM CST
Orient EuroPharma Revenue
Orient EuroPharma had revenue of 1.16B TWD in the quarter ending March 31, 2025, with 4.70% growth. This brings the company's revenue in the last twelve months to 4.44B, down -2.25% year-over-year. In the year 2024, Orient EuroPharma had annual revenue of 4.39B, down -4.37%.
Revenue (ttm)
4.44B
Revenue Growth
-2.25%
P/S Ratio
0.94
Revenue / Employee
13.11M
Employees
339
Market Cap
4.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.39B | -200.59M | -4.37% |
| Dec 31, 2023 | 4.59B | -138.56M | -2.93% |
| Dec 31, 2022 | 4.73B | -36.57M | -0.77% |
| Dec 31, 2021 | 4.77B | -616.63M | -11.45% |
| Dec 31, 2020 | 5.38B | -709.60M | -11.65% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |